PSIP1 and cancer: In combination with database-based mRNA analysis, a significant increase in LEDGF/p75 expression in cancer tissue lysates was confirmed, thereby highlighting the potential of LEDGF/p75 as a biomarker for assessing the likelihood of cancer progression.